APOL1 Risk Variants, Acute Kidney Injury, and Death in Participants With African Ancestry Hospitalized With COVID-19

Adriana M Hung1,2, Shailja C Shah3,4, Alexander G Bick5

  • 1Tennessee Valley Healthcare System, Nashville Campus, Nashville.

JAMA Internal Medicine
|January 28, 2022
PubMed

Insights

Individuals with African ancestry carrying two APOL1 risk variants face higher risks of acute kidney injury (AKI) and death following COVID-19 hospitalization. This association holds true even for those with normal kidney function before infection.

Area of Science:

  • Nephrology
  • Genetics
  • Infectious Diseases

Background:

  • Coronavirus disease 2019 (COVID-19) is a significant risk factor for acute kidney injury (AKI), leading to high mortality rates.
  • Individuals of African ancestry with two copies of apolipoprotein L1 (APOL1) risk variants (G1 or G2) exhibit increased susceptibility to kidney disease.

Purpose of the Study:

  • To investigate the association between APOL1 high-risk genotype and the risk of developing COVID-19-associated AKI and mortality.
  • To determine if APOL1 risk variants influence AKI severity and death in patients hospitalized with COVID-19.

Main Methods:

  • A retrospective cohort study involving 990 veterans of African ancestry hospitalized with COVID-19.
  • Genetic information on APOL1 risk variants was analyzed, comparing the high-risk group (two risk variants) with the low-risk group (one or zero risk variants).
  • Multivariable logistic regression was used to assess the association between APOL1 status and outcomes, adjusting for comorbidities and other risk factors. Subgroup analysis was performed for individuals with normal kidney function.

Main Results:

  • The APOL1 high-risk group (12.6% of participants) showed significantly higher odds of developing AKI (OR, 1.95), increased AKI severity (OR, 2.03), and higher mortality (OR, 2.15) compared to the low-risk group.
  • These associations remained significant even in the subgroup of patients with normal kidney function prior to hospitalization (AKI OR, 1.93).
  • Overall, 39.6% of patients developed AKI, 14% had severe AKI, and 12.3% died.

Conclusions:

  • APOL1 kidney risk variants are significantly associated with an increased risk of AKI, AKI severity, and death in individuals of African ancestry hospitalized with COVID-19.
  • The findings highlight a genetic predisposition to severe kidney outcomes following COVID-19 infection in this population.
  • The increased risk associated with APOL1 variants is evident even in individuals without pre-existing kidney impairment.
Abstract

Related Concept Videos

Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...